EODData

MEMBERSHIP REGISTER LOG IN

FRA, PHGN: Pharming Group NV

23 Dec 2025
LAST:

1.443

CHANGE:
 0.06		OPEN:
1.450		HIGH:
1.450		ASK:
0.000		VOLUME:
544
CHG(%):
3.96		PREV:
1.388		LOW:
1.443		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 251.4501.4501.4431.443544
22 Dec 251.3881.3881.3881.388147
19 Dec 251.3731.3731.3731.373147
18 Dec 251.4151.4151.4151.415147
17 Dec 251.3671.3671.3671.367100
16 Dec 251.4171.4171.4171.4176.0K
15 Dec 251.5001.5001.4291.4426.0K
12 Dec 251.4641.4781.4641.4786
10 Dec 251.4441.4441.4441.444356
09 Dec 251.4711.4711.4711.471356

PROFILE

Name:Pharming Group NV
About:Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Darwinweg 24, Leiden, Netherlands, 2333 CR
Website:https://www.pharming.com
ISIN:NL0010391025

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:56.95 
Forward P/E:-37.27 
PEG Ratio:-37.27 
Price to Sales:2.28 
Price to Book:3.19 
Profit Margin:-0.02 
Operating Margin:0.03 
Return on Assets:0.03 
Return on Equity:-0.04 
Revenue:294.94M 
EBITDA:12.47M 
Shares:685.15M 
Market Cap:988.67M 

TECHNICAL INDICATORS

MA5:1.403.3%
MA10:1.421.3%
MA20:1.431.1%
MA50:1.338.8%
MA100:1.2416.6%
MA200:1.0438.5%
STO9:57.14
STO14:61.22
RSI14:53.27
WPR14:-31.30
MTM14:0.09
ROC14:0.06 
ATR:0.05 
Week High:1.450.5%
Week Low:1.375.6%
Month High:1.535.7%
Month Low:1.3538.5%
Year High:1.535.7%
Year Low:0.67114.7%
Volatility:73.63 

RECENT SPLITS

Date Ratio
05 Mar 20131-10